Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Auditor change
Appointed director
Quarterly results
|
|
Mirati Therapeutics, Inc. (MRTX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 3.8% stake in Mirati Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 8.6% stake in Mirati Therapeutics Inc. |
| 02/06/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 5.9% stake in Mirati Therapeutics, Inc. |
| 02/11/2022 |
SC 13G/A
| Avoro Capital Advisors LLC reports a 9.2% stake in Mirati Therapeutics, Inc. |
| 02/10/2022 |
SC 13G/A
| VANGUARD GROUP INC reports a 8% stake in Mirati Therapeutics Inc. |
| 02/09/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/10/2022 |
SC 13G/A
| BlackRock Inc. reports a 5% stake in Mirati Therapeutics Inc |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Avoro Capital Advisors LLC reports a 9% stake in Mirati Therapeutics, Inc. |
| 02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/08/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/29/2021 |
SC 13G/A
| BlackRock Inc. reports a 8.5% stake in Mirati Therapeutics Inc |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Cormorant Asset Management, LLC reports a 4.2% stake in Mirati Therapeutics, Inc. |
| 02/14/2020 |
SC 13G/A
| venBio Select Advisor LLC reports a 9.9% stake in Mirati Therapeutics, Inc. |
| 02/07/2020 |
SC 13G/A
| FMR LLC reports a 5.1% stake in MIRATI THERAPEUTICS INC |
| 02/05/2020 |
SC 13G/A
| BlackRock Inc. reports a 7% stake in Mirati Therapeutics Inc |
| 11/14/2019 |
SC 13G/A
| Cormorant Asset Management, LLC reports a 5.4% stake in Mirati Therapeutics, Inc. |
| 08/12/2019 |
SC 13G/A
| FMR LLC reports a 7.2% stake in MIRATI THERAPEUTICS INC ? |
| 07/25/2019 |
SC 13G/A
| venBio Select Advisor LLC reports a 9.7% stake in Mirati Therapeutics, Inc. |
| 03/11/2019 |
SC 13G/A
| FMR LLC reports a 12.7% stake in MIRATI THERAPEUTICS INC |
| 02/14/2019 |
SC 13G/A
| Cormorant Asset Management, LLC reports a 5.1% stake in Mirati Therapeutics, Inc. |
| 02/14/2019 |
SC 13G/A
| venBio Select Advisor LLC reports a 14.8% stake in Mirati Therapeutics, Inc. |
| 02/13/2019 |
SC 13G/A
| Broadfin Capital, LLC reports a 0.6% stake in Mirati Therapeutics, Inc. |
| 02/13/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/20/2017 |
SC 13G/A
| Broadfin Capital, LLC reports a 9.9% stake in Mirati Therapeutics, Inc. |
| 10/03/2017 |
SC 13G/A
| venBio Select Advisor LLC reports a 15% stake in Mirati Therapeutics, Inc. |
| 02/09/2017 |
SC 13G/A
| Mirati Therapeutics, Inc. reports a 7.7% stake in Mirati Therapeutics, Inc. |
| 01/09/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/09/2016 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
|
|